Lebanon vs Saudi Arabia: Proportion of bloodstream infection due to methicillin-resistant
Lebanon
50.0%
in 2023
Saudi Arabia
49.5%
in 2023
Lebanon rank
12th
Saudi Arabia rank
13th
Proportion of bloodstream infection due to methicillin-resistant over time
- Lebanon
- Saudi Arabia
How they compare
Lebanon currently reports 50.0% against 49.5% in Saudi Arabia, a difference of 0.5%.
The two have swapped places 1 time across 7 shared years of data; in 2017 it was Saudi Arabia ahead.
Lebanon ranks 12th and Saudi Arabia ranks 13th of 55 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lebanon | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.8% | 42.8% | 25.1% | Saudi Arabia |
| 2020s | 43.7% | 50.3% | 6.6% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Lebanon or Saudi Arabia?
- Lebanon, at 50.0% against 49.5% in Saudi Arabia as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Lebanon and Saudi Arabia?
- 0.5%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Saudi Arabia?
- 7 years are reported by both, from 2017 to 2023.
- How do Lebanon and Saudi Arabia rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Lebanon ranks 12th and Saudi Arabia ranks 13th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.